Explore the efficacy of VOWST® used sequentially after antibiotics

Boxing gloves image

VOWST used following antibiotics was studied in a rigorous phase 3 clinical development program1,2

Shield icon

VOWST SAFETY

Explore the safety profile

SEE THE SAFETY DATA
2-step dosing icon

2-STEP
ORAL DOSING

that is self-administered at home

GET VOWST DOSING DETAILS

ABX, antibiotics.

REFERENCES: 1. Feuerstadt P, Louie TJ, Lashner B, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N Engl J Med. 2022;386:220-229. doi:10.1056/NEJMoa2106516 2. Sims MD, Khanna S, Feuerstadt P, et al. Safety and tolerability of SER-109 as an investigational microbiome therapeutic in adults with recurrent Clostridioides difficile infection: a phase 3, open-label, single-arm trial. JAMA Netw Open. 2023;6(2):e2255758. doi:10.1001/jamanetworkopen.2022.55758 3. VOWST [Prescribing Information]. Cambridge, MA: Seres Therapeutics, Inc. and Nestlé Health Science. 06/2024. 4. Cohen SH, Louie TJ, Sims M, et al. Extended follow-up of microbiome therapeutic SER-109 through 24 weeks for recurrent Clostridioides difficile infection in a randomized clinical trial. JAMA. 2022;328(20):2062-2064. doi:10.1001/jama.2022.16476 5. Data on File. Nestlé Health Science.

​ 
Nestlé Health Science
Seres Therapeutics